Onset Therapeutics Announces Company Launch
Development and commercialization of novel therapies with clinical enhancements over existing products in the market is the core of Onset's strategy. With significant development capabilities that include formulation development through GMP manufacturing, the company looks to market numerous topical products within the wound care and dermatology markets in 2006. In addition, the company has a full pipeline of products that it intends to launch over the next 3 years.
"We strive to provide novel, optimized and cost effective pharmaceutical products to the healthcare market", states Michael Heffernan, President of Onset Therapeutics. "Our scientists pride themselves on thoroughly understanding the specific clinical needs and limitations of currently available treatments for skin conditions and wound care, and then tailoring their product development efforts to optimize the treatment of these conditions, resulting in revolutionary products that further advance patient care".
Onset Therapeutics expects to launch several wound care products in 2006, in addition to numerous dermatology products incorporating the company's novel Foam Vehicle Technology.
About Onset Therapeutics
Onset Therapeutics is a privately held specialty pharmaceutical company focusing on the development and commercialization of novel, patent protected topical products for the treatment of wounds and skin disorders. For more information, please visit the company's website at www.onsettx.com.
Contact: Onset Therapeutics Mary Theriault, 401-667-7337 mtheriault@onsettx.com
Source: Onset Therapeutics